Please login to the form below

Hydroxychloroquine

This page shows the latest Hydroxychloroquine news and features for those working in and with pharma, biotech and healthcare.

Or that taking ivermectin, a parasitic agent used in veterinary medicine, or hydroxychloroquine may help reduce being hospitalised for COVID-19.

WHO to test three more potential COVID-19 treatments

Last year, WHO announced that four drugs tested in its Solidarity trial, touted as effective treatments for severe COVID-19 infection – remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon – had little or no ... Hydroxychloroquine and
WHO trial casts doubt on remdesivir's efficacy

The interim results, published on the pre-print server medRxiv, showed that remdesivir, along with hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have ‘little or no effect’ on 28-day
Pearls of wisdom

Hydroxychloroquine does not work. Ingestion of disinfectants, hand sanitiser and light into the body do not work either.
Speed kills

On 22 May, The Lancet published a research paper about hydroxychloroquine, the antimalarial drug, as a potential treatment for COVID-19. ... claimed that the use of hydroxychloroquine carried a greater risk of heart arrhythmia and death.
WHO takes stock of global COVID-19 R&D progress

The WHO also took the decision to discontinue the Solidarity Trial’s hydroxychloroquine and lopinavir/ritonavir arms following a review of evidence obtained at the interim analysis. ... These results showed that neither hydroxychloroquine nor

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

How will COVID-19 affect uptake of vaccinations against other diseases?

that halted hydroxychloroquine trials due to data inconsistencies, if repeated in the context of SARS-CoV-2 vaccines, risk undermining public confidence in vaccines.
COVID-19: the race to find a vaccine

Other antivirals including hydroxychloroquine – a drug championed by President Donald Trump – and favipiravir are also in clinical development, raising hopes that researchers will find a drug with some level of efficacy
As COVID-19 takes over the world, biopharma fights back

A standard malaria treatment: chloroquine and hydroxychloroquine. A decades-old antimalaria drug, chloroquine, entered the global spotlight in March after US President Donald Trump touted it as a potentially effective coronavirus ... treatment. Since then

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Associate Director - Global Healthcare Consulting: Highly competitive salary

Early Access Program - Regulatory Affairs (EAP-RA): Highly competitive salary

Add my company

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Rare diseases: not so rare after all: The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape: Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA: It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...

Email:
Password: